Corbus(CRBP)

石药集团巨石生物独家授权Corbus的SYS6002第一阶段临床试验数据取得积极进展

股界一粒沙01-27 02:24

$Corbus制药控股(CRBP)$ $新诺威(SZ300765)$ $石药集团(01093)$
Corbus数据公布后股价暴涨，截止发帖时间已经上涨3倍多。
近日，石药集团/Corbus在2024年(ASCO-GU2024)上，公布了靶向nectin-4抗体药物偶联物（ADC）SYS6002的I期剂量递增数据。
具体数据可以查询Corbus发布的公告...查看全文

产业链观察01-26 22:41

$Corbus制药控股(CRBP)$ 今天介绍新的下一代nectin-4#ADC药物# 的早期ADC数据。股价翻倍。查看全文

当期报告

Corbus(CRBP)01-26 20:55

$Corbus制药控股(CRBP)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0000950170-24-007703  Act: 34  Size: 28 MB 网页链接查看全文

首次持股声明

Corbus(CRBP)01-31 05:25

$Corbus制药控股(CRBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000929638-24-000303  Size: 7 KB 网页链接查看全文

首次持股声明

Corbus(CRBP)03-01 06:15

$Corbus制药控股(CRBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-24-004119  Size: 6 KB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)02-29 06:05

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000053  Act: 34  Size: 81 KB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)01-27 05:35

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-001240  Act: 34  Size: 84 KB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)02-06 05:55

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000374  Act: 34  Size: 110 KB 网页链接查看全文

当期报告

Corbus(CRBP)02-05 21:15

$Corbus制药控股(CRBP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0000950170-24-011013  Act: 34  Size: 29 MB 网页链接查看全文

当期报告

Corbus(CRBP)03-21 05:15

$Corbus制药控股(CRBP)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-034271  Act: 34  Size: 148 KB 网页链接查看全文

持股变动声明

$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005284  Size: 7 KB 网页链接

当期报告

$Corbus(CRBP)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0000950170-24-043417  Act: 34  Size: 650 KB 网页链接

其他

$Corbus(CRBP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-043418  Act: 34  Size: 42 KB 网页链接

其他

$Corbus(CRBP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-040247  Act: 34  Size: 171 KB 网页链接

其他

$Corbus(CRBP)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-040250  Act: 34  Size: 2 MB 网页链接

股东委托书协议

$Corbus(CRBP)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-040242  Act: 34  Size: 2 MB 网页链接

其他

$Corbus(CRBP)$ PRE 14A Other preliminary proxy statements Accession Number: 0000950170-24-035466  Act: 34  Size: 1 MB 网页链接

生效批准

$Corbus(CRBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000696  Act: 33  Size: 1 KB 网页链接

招股说明书

$Corbus制药控股(CRBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0000950170-24-034262  Act: 33  Size: 245 KB 网页链接

年度财报「修正」

$Corbus制药控股(CRBP)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034266  Act: 34  Size: 3 MB 网页链接